Doctor profile · Federal record
Dr. ALAIN BOUCHARD, MD
Cardiovascular Disease Physician (CMS: CARDIOVASCULAR DISEASE (CARDIOLOGY)) · Interventional Cardiology Physician · BIRMINGHAM, AL
- NPI 1659336790
- Accepts Medicare
- MIPS 87.0 / 100 · 2023
- 47 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
2700 10TH AVE SOUTH, BUILDING 2, SUITE 305
BIRMINGHAM, AL 35205
(205) 939-7100 - Additional location
-
801 Princeton Ave SW, Suite 706
Birmingham, AL 352111310
(205) 780-4330
fax (205) 780-7775 - Mailing address
-
801 PRINCETON AVE SW, SUITE 706
BIRMINGHAM, AL 352111310
Credentials & registration
- NPI registered
- April 2006 — 20 yrs on file
- Profile last updated
- February 28, 2020
- Year of graduation
- 1979 — 47 yrs since
- Specialty taxonomy
- 207RC0000X — NUCC code
- State licenses (2)
- Alabama #00013058 · Alabama #MD.13058
- Medicaid
- AL #000082651
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1659336790. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,598
Distinct HCPCS
10
Medicare allowed
$213,873
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
93000 |
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 538 | 413 | $13 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 515 | 385 | $118 | |
93306 |
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 292 | 277 | $168 | |
93296 |
Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 212 | 80 | $20 | |
J2785 |
Injection, regadenoson, 0.1 mg | 156 | 39 | $60 | |
93294 |
Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 142 | 53 | $28 | |
A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose | 100 | 50 | $108 | |
93295 |
Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 72 | 29 | $35 | |
78452 |
Nuclear medicine studies of heart muscle at rest and with stress and spect | 71 | 71 | $293 | |
93880 |
Ultrasound of both sides of head and neck blood flow | 67 | 67 | $167 |
In context: peer comparison
Among 34 peers in this city , average services per provider: 148. This provider delivers 18× the peer median.Open Payments
Industry payments received
All-time total
$582
Transactions
30
Manufacturers
8
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | 18 | $297.64 | |
| Medtronic, Inc. | 1 | $90.93 | |
| E.R. Squibb & Sons, L.L.C. | 3 | $57.85 | |
| Kiniksa Pharmaceuticals International, plc | 2 | $39.52 | |
| AstraZeneca Pharmaceuticals LP | 2 | $29.88 | |
| SCPHARMACEUTICALS INC. | 2 | $28.34 | |
| SANOFI-AVENTIS U.S. LLC | 1 | $22.59 | |
| Amgen Inc. | 1 | $15.00 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
6,251
Patients
1,967
Total drug cost
$1,567,433
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Metoprolol Succinate | Generic | 1,016 | 326 | $25,702 |
| Rosuvastatin Calcium | Generic | 787 | 270 | $34,819 |
| Eliquis (Apixaban) | Brand | 705 | 138 | $595,128 |
| Spironolactone | Generic | 465 | 165 | $5,944 |
| Entresto (Sacubitril/Valsartan) | Brand | 433 | 81 | $400,680 |
| Jardiance (Empagliflozin) | Brand | 419 | 113 | $432,979 |
| Clopidogrel (Clopidogrel Bisulfate) | Brand | 402 | 129 | $6,262 |
| Atorvastatin Calcium | Generic | 400 | 139 | $9,241 |
| Amlodipine Besylate | Generic | 389 | 144 | $3,388 |
| Isosorbide Mononitrate Er (Isosorbide Mononitrate) | Brand | 228 | 81 | $5,464 |